This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Nov. 6, 2012


Bill would tighten pharmacy rules
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Lawmakers are assembling legislation that would give the Food and Drug Administration clearer authority to regulate large pharmacies that mix customized drugs like the one tied to a deadly meningitis outbreak. Recently, Rep. Edward J. Markey, D-Mass., plans to introduce a bill that would require large compounding pharmacies to meet the same sterility, manufacturing and record-keeping standards as those required of large drug makers. Rep. Rosa DeLauro, D-Conn., also plans to introduce legislation after the election to strengthen the agency's regulatory authority. More

 Area and Association News

Join the APAP initiative today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Over 850 cases of pertussis were reported in Arizona in 2011. There have already been over 750 cases reported along with one infant death so far in 2012. All healthcare personnel and staff are asked to get immunized against pertussis to decrease the spread of this contagious disease. Please join the Arizona Pharmacy Association and Arizona Partners Against Pertussis in a statewide campaign to reduce pertussis exposure to patients. Your support of this initiative is crucial. More

Holiday shopping is upon us
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Remember to purchase your gift cards through AzPA and support pharmacy education in Arizona. Learn more.

Grow your elderly client customer base by offering our Pill Pak system...

Designed to reduce the chance of medication errors. An easy to use multidose compliance package, available in both cold seal and heat seal formats, it helps your clients maintain their independence and take their multiple medications accurately!

For more information on Pill Pak or our other medication compliance products, visit or contact
Diane LaTourelle:

Shop and support AzPA
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The next time you shop on, visit the AzPA website first and click on the portal on the home page. When you enter through the AzPA website, a portion of your total purchases will come back to AzPA. Bookmark this link.

Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

Don't forget to vote
Share   Share on FacebookTwitterShare on LinkedinE-mail article
Today is Election Day. Please vote!

 Pharmacy Updates

FDA: More tainted products at firm tied to meningitis outbreak
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Lab tests have found bacteria in two other medical products made by the Massachusetts-based specialty pharmacy at the center of the ongoing fungal meningitis outbreak, Food and Drug Administration officials recently said. Tests for fungal contamination in both products are pending and FDA officials reiterated their concern about the safety of any medical products made by the New England Compounding Center. Since the meningitis outbreak began more than a month ago, the company has recalled all of its medical products and shut down its manufacturing plant in Framingham, Mass. More

Pharmacies take more active role in alerts on patients' drugs
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Physicians soon could be hearing more often from their patients' pharmacies. Walgreens, which operates 7,944 stores in all 50 states, recently announced the launch of its WellTransitions program for patients at high risk of readmission within 30 days of hospital stays. The program includes providing medication lists to patients' primary care physicians and taking steps to make follow-up appointments. Walgreens also will provide medication review, bedside medication delivery and patient counseling. About a dozen health systems had signed on as of mid-October, and another dozen were negotiating to enlist the program's help. More

The #1 Selling Brain Health Supplement in Drug Stores Nationally.
Healthier Brain • Sharper Mind • Protect Memories
As we age we lose calcium-binding proteins that protect our brain cells. This protein loss affects our ability to learn, retain memories, think and concentrate.* Prevagen® (apoaequorin) replaces these proteins in the body and helps protect our cells during this natural process of aging.* Over the counter, visit:
Harness the Rejuvenation Power of Your Own Stem Cells
Important benefits of Stem Cell 100™
  • Powerful anti-aging properties
  • Provides immune support
  • Promotes younger looking skin
  • Supports cardiovascular health
  • Renews health and vitality

  • Lubrizol

    Noveon AA-1 Polycarbophil, USP is a high molecular weight acrylic acid polymer crosslinked with divinyl glycol. It provides excellent bioadhesive properties and has been used extensively to enhance the delivery of active ingredients to various mucous membranes.

     In the News

    Hormone replacement therapy may reduce Alzheimer's risk
    Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Women who use hormone replacement therapy within five years after the onset of menopause may significantly decrease their risk of developing Alzheimer's disease, according to the results of a study published online in Neurology. The study adds to a longstanding debate among researchers over the role of HRT in neuroprotection. Some studies have indicated that HRT is helpful in preventing dementia, while others have indicated the opposite. In general, observational studies have tended to show protective qualities, but the Women's Health Initiatives Memory Study, which was stopped early in 2002 due to concerns about cardiac and cancer risks, actually found that HRT increased the risk of dementia. More

    Mumps outbreak stemmed by 3rd MMR dose
    Medscape News (free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    A third dose of measles-mumps-rubella vaccine given to children and teenagers already covered by two-dose vaccines helped to stem a mumps outbreak, according to a study published in Pediatrics. However, the authors do not recommend adding a routine third MMR dose to national vaccine programs. More

    Pharmacists now target of law-enforcement in Florida's Rx-drug battle
    Orlando Sentinel    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    When a ring of suspected prescription drug traffickers called Ramesh Pathak and told him they were coming into his Orlando pharmacy, the pharmacist had a drill, authorities say. He turned off the surveillance cameras. He vetted their fake prescriptions to make sure they looked real enough. He'd have their oxycodone pills counted and ready. Recently filed court documents show how in the past year, as Metropolitan Bureau of Investigation agents dismantled local prescription drug rings, they also identified the pharmacists who supply the pills that end up with addicts and on central Florida streets. More

    Doctors pressured to prescribe opiods to addicts
    Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    A number of factors prod doctors to prescribe opioids even when they have good reason to believe they will be abused or diverted, according to an article by Dr. Anna Lembke, an assistant professor in the department of psychiatry at Stanford University. Lembke's perspective was published in the New England Journal of Medicine. Lembke notes that prescription opioid abuse is an epidemic, with up to 2.4 million current opioid abusers in the U.S. She points out that approximately 60 percent of opioids that are abused are obtained either directly or indirectly from a doctor's prescription and that in many cases doctors are aware that patients are abusing opioids or diverting them to abusers. The question is why doctors continue to prescribe opioids under these circumstances. More

     FDA News

    Unanimous FDA panel backs anthrax drug
    MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    An FDA panel has unanimously voted in favor of approving the monoclonal antibody raxibacumab for treating inhalational anthrax, just three years after the agency denied approval of the same drug. The Anti-Infective Drugs Advisory Committee recently voted 18-0 that raxibacumab is effective in treating humans who inhaled anthrax. They also voted 16-1 with one abstention that the agent was effective. More

    FDA OKs expanded use of Xarelto to treat, reduce recurrence of blood clots
    The Associated Press via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Johnson & Johnson's Xarelto received an expanded indication as the Food and Drug Administration recently approved the blood thinner both to treat and to reduce the risk of recurrence of deep vein thrombosis and pulmonary embolism. Xarelto is already approved for three uses: reducing risk of blood clots in people who've had knee replacement surgery or hip replacement surgery and for reducing stroke risk in people with a common irregular heart rhythm — atrial fibrillation — not caused by a heart valve problem. More

    FDA: Shortage of 6 life-saving drugs may escalate following Ameridose recall
    RTT News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Following the voluntary shutdown of Ameridose LLC and the recall of its products, the FDA has announced that supplies of certain life-saving drugs for some healthcare systems may be affected. Ameridose is a sister company of New England Compounding Center. Under a voluntary agreement with the Massachusetts Board of Registration in Pharmacy, Ameridose ceased all pharmacy and manufacturing operations starting on Oct. 10. More

    FDA: Bleeding risk with dabigatran etexilate similar to warfarin
    Medscape News (free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Bleeding rates associated with the use of dabigatran etexilate appear to be no higher than bleeding rates associated with warfarin when used as an anticoagulant to reduce the risk for stroke in patients with nonvalvular atrial fibrillation. According to a safety communication sent by MedWatch, the Food and Drug Administration's safety information and adverse event reporting program, the finding "is consistent" with observations from the large clinical trial, the Randomized Evaluation of Long-term Anticoagulant Therapy trial, used to approve dabigatran. More

    AzPA Pharmacy Flash
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Danielle Wegert, Content Editor, 469.420.2696   
    Contribute news

    This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
    Recent issues
    Nov. 6, 2012
    Oct. 30, 2012
    Oct. 23, 2012
    Oct. 16, 2012

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063